Cambridge Security Seals Launches A-MVB™ Line of Tamper-Evident Seals Equipped to Combat the Spread of Viruses and Diseases

NEXT STORY
Notable Appoints Biotech Veteran Joseph Wagner PhD as Chief Scientific Officer
PREV STORY
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

author_avatar
NASDAQ Market News

ZIOPHARM Oncology Announces Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma to be Presented at the 2017 ASCO Annual Meeting

BOSTON, May 17, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

ASTRAZENECA COMPLETES US LICENSING AGREEMENT WITH IRONWOOD PHARMACEUTICALS FOR LESINURAD

AstraZeneca today announced that it has completed the licensing agreement (https://www.astrazeneca.com/media-centre/press -releases/2016/astrazeneca-enters-into-us-licensing-agreement-with-ironwood -pharmaceuticals-for-lesinurad-26042016.html) with Ironwood ...

author_avatar
NASDAQ Market News